These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 15685549

  • 1. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha.
    Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y, Otsuka J, Okamura S, Fujita S, Harada M.
    Gastroenterology; 2005 Feb; 128(2):376-92. PubMed ID: 15685549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies.
    Di Sabatino A, Pender SL, Jackson CL, Prothero JD, Gordon JN, Picariello L, Rovedatti L, Docena G, Monteleone G, Rampton DS, Tonelli F, Corazza GR, MacDonald TT.
    Gastroenterology; 2007 Jul; 133(1):137-49. PubMed ID: 17631138
    [Abstract] [Full Text] [Related]

  • 6. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R, Zimmer M, Bartsch B, Waldner MJ, Atreya I, Neumann H, Hildner K, Hoffman A, Kiesslich R, Rink AD, Rau TT, Rose-John S, Kessler H, Schmidt J, Neurath MF.
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [Abstract] [Full Text] [Related]

  • 7. Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: Therapeutic implications.
    Szondy Z, Pallai A.
    Pharmacol Res; 2017 Jan; 115():124-132. PubMed ID: 27888159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated 'reverse signaling'.
    Xin L, Wang J, Zhang H, Shi W, Yu M, Li Q, Jiang X, Gong F, Gardner K, Li QQ, Li Z.
    Int J Mol Med; 2006 Nov; 18(5):885-92. PubMed ID: 17016618
    [Abstract] [Full Text] [Related]

  • 11. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ.
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.
    Nesbitt A, Fossati G, Bergin M, Stephens P, Stephens S, Foulkes R, Brown D, Robinson M, Bourne T.
    Inflamm Bowel Dis; 2007 Nov; 13(11):1323-32. PubMed ID: 17636564
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands.
    Sisto M, D'Amore M, Caprio S, Mitolo V, Scagliusi P, Lisi S.
    Ann N Y Acad Sci; 2009 Aug; 1171():407-14. PubMed ID: 19723083
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.
    Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, Hommes DW.
    Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706
    [Abstract] [Full Text] [Related]

  • 18. Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications.
    Pallai A, Kiss B, Vereb G, Armaka M, Kollias G, Szekanecz Z, Szondy Z.
    J Immunol; 2016 Feb 01; 196(3):1146-57. PubMed ID: 26729808
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
    Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D, RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group.
    Arthritis Res Ther; 2006 Feb 01; 8(4):R114. PubMed ID: 16859506
    [Abstract] [Full Text] [Related]

  • 20. Why do anti-tumor necrosis factor antibodies work in Crohn's disease?
    Sands BE.
    Rev Gastroenterol Disord; 2004 Feb 01; 4 Suppl 3():S10-7. PubMed ID: 15580148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.